Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Sequent Scientific posts Rs 30.53 crore profit for Q2Sequent Scientific posts Rs 30.53 crore profit for Q2
    Drugmaker Hikma cuts generics sales forecast a third timeDrugmaker Hikma cuts generics sales forecast a third time
    Sterling Biotech Case : Dont let shark run away for catching small fish, Court tells EDSterling Biotech Case : Don't let shark run away for catching small fish, Court tells ED
    Novartis India Q2 net up 18 percent at Rs 26 croreNovartis India Q2 net up 18 percent at Rs 26 crore
    UE LifeSciences in distribution partnership with GE HealthcareUE LifeSciences in distribution partnership with GE Healthcare
    Divis Labs soars 8 percent as USFDA closes out warning letter on Vizag unitDivis Labs soars 8 percent as USFDA closes out warning letter on Vizag unit
    CGHS medicine supplier SURRENDERS Rs 200 crore black moneyCGHS medicine supplier SURRENDERS Rs 200 crore black money
    Aurobindo Pharma Q2 net up 29 percent at Rs 780.97 croreAurobindo Pharma Q2 net up 29 percent at Rs 780.97 crore
    Zydus gets regulatory nod to market Lipaglyn in MexicoZydus gets regulatory nod to market Lipaglyn in Mexico
    Morepen Labs ties up with Vesale Pharma of BelgiumMorepen Labs ties up with Vesale Pharma of Belgium
    Alkem Labs Q2 Net up 14 percent at Rs 327.44 croreAlkem Labs Q2 Net up 14 percent at Rs 327.44 crore
    FDA OKs Merck drug that prevents infection post-stem cell transplantFDA OKs Merck drug that prevents infection post-stem cell transplant
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok